KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBITDA: 2009-2024

Historic EBITDA for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $61.4 million.

  • Incyte's EBITDA rose 203.60% to $443.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2899.92%. This contributed to the annual value of $61.4 million for FY2024, which is 90.11% down from last year.
  • As of FY2024, Incyte's EBITDA stood at $61.4 million, which was down 90.11% from $620.5 million recorded in FY2023.
  • In the past 5 years, Incyte's EBITDA registered a high of $620.5 million during FY2023, and its lowest value of -$263.7 million during FY2020.
  • In the last 3 years, Incyte's EBITDA had a median value of $579.4 million in 2022 and averaged $420.4 million.
  • In the last 5 years, Incyte's EBITDA slumped by 165.59% in 2020 and then surged by 322.16% in 2021.
  • Yearly analysis of 5 years shows Incyte's EBITDA stood at -$263.7 million in 2020, then skyrocketed by 322.16% to $585.8 million in 2021, then dropped by 1.08% to $579.4 million in 2022, then grew by 7.09% to $620.5 million in 2023, then tumbled by 90.11% to $61.4 million in 2024.